![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Korean Firm Warned for Glucose Monitor Errors
Korean Firm Warned for Glucose Monitor Errors
May 12, 2020
The FDA has issued a warning letter to South Korean devicemaker Philosys over adverse event reporting for its blood glucose monitor.
The company failed to notify the agency following a complaint from a customer about its Gmate VOICE blood glucose monitor. The device issued a faulty high glucose reading that led to hypoglycemia in the patient due to excess insulin.
The company claimed it submitted a medical device report to the FDA about the complaint, but the agency said it never received a report.
Upcoming Events
-
21Oct